Items where authors include "Tuthill, M."

Article

Rossi, S.H., Choueiri, T.K., Jewett, M. orcid.org/0000-0001-7162-5380 et al. (84 more authors) (2025) What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An international neoadjuvant kidney cancer consortium Delphi study. Annals of Oncology. ISSN 0923-7534

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G. orcid.org/0000-0002-9952-8440, Brown, S. orcid.org/0000-0002-7975-7537 et al. (24 more authors) (2023) Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: a randomized phase II trial (PRISM). Journal of Clinical Oncology. JCO2300236. ISSN 0732-183X

Starkey, T., Ionescu, M.C., Tilby, M. et al. (64 more authors) (2023) A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP). Scientific Reports, 13. 11327. ISSN 2045-2322